CASP10 (Caspase 10)

Apoptosis Initiator and Immune Regulator

Gene Information Card

Symbol CASP10
Full Name Caspase 10
Gene Type Protein coding
Chromosomal Location 2q33.1
NCBI Gene ID 843 ncbi.nlm.nih.gov/gene/843
Ensembl ID ENSG00000003400
UniProt ID Q92851
OMIM ID 601762
HGNC ID 1500
Aliases MCH4, FLICE2, ALPS2

Description

CASP10 (caspase 10) is a member of the cysteine-aspartic acid protease (caspase) family. It functions as an initiator caspase in the extrinsic apoptosis pathway, activated by death receptors such as Fas. Upon activation, it cleaves downstream effector caspases (e.g., caspase-3, -7) to execute programmed cell death. CASP10 also plays roles in immune regulation and T-cell homeostasis. Mutations in CASP10 are associated with autoimmune lymphoproliferative syndrome type II (ALPS II) and certain cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Autoimmune lymphoproliferative syndrome type II (ALPS2) Loss-of-function mutations impair Fas-mediated apoptosis, leading to defective lymphocyte apoptosis and lymphoproliferation. OMIM #603909; ClinVar
Gastric cancer Reduced CASP10 expression or inactivating mutations may contribute to evasion of apoptosis. COSMIC; NCBI PubMed
Non-Hodgkin lymphoma Somatic mutations in CASP10 are found in some cases, potentially disrupting apoptosis. COSMIC; NCBI PubMed

Expression Profile

Tissue Expression
Tissue nTPM level
Lymph node 12.5 Medium
Spleen 10.3 Medium
Whole blood 5.1 Low
Small intestine 4.8 Low
Brain 1.2 Not detected
Cell Line Expression
Cell Line nTPM Notes
Jurkat (T-cell leukemia) 8.7 High expression
HeLa (cervical carcinoma) 6.2 Moderate expression
HEK293 (embryonic kidney) 4.1 Low expression
MCF7 (breast carcinoma) 3.5 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1022G>A (p.Arg341Gln) Missense Rare Dominant-negative effect; associated with ALPS2
c.1A>G (p.Met1Val) Missense Rare Loss of function; reduced apoptosis
c.1339C>T (p.Arg447*) Nonsense Rare Loss of function; truncated protein
Mutation functional classification

Loss of Function (LOF)

Mutations that reduce or abolish caspase-10 proteolytic activity, impairing apoptosis.

Gain of Function (GOF)

Not well documented; no confirmed gain-of-function mutations reported.

Dominant Negative (DN)

Mutations such as p.Arg341Gln interfere with wild-type caspase-10 function, leading to ALPS2.

Gene Ontology (GO)

• cysteine-type endopeptidase activity involved in apoptotic process • cysteine-type endopeptidase activity
• protein binding • apoptotic process
• extrinsic apoptotic signaling pathway via death domain receptors • activation of cysteine-type endopeptidase activity involved in apoptotic process

Pathways

Fas signaling pathway (CD95)
Extrinsic apoptosis pathway
TNF signaling pathway

Protein Summary

Caspase-10 is a 521-amino acid protein (55 kDa) containing an N-terminal death effector domain (DED) and a C-terminal caspase domain. It is synthesized as a zymogen and activated by proteolytic cleavage. The active enzyme forms a heterotetramer of two large and two small subunits. It is primarily cytosolic and recruited to death-inducing signaling complex (DISC) upon death receptor activation.

Related Products

Product name Cat.No. Species Gene ID
CASP10 Knockout HEK293 Cell Line EDJ-KQ1476 Human 843 Details Get a Quote
CASP10 Knockout A-549 Cell Line EDJ-KQ21054 Human 843 Details Get a Quote
CASP10 Knockout HCT 116 Cell Line EDJ-KQ21055 Human 843 Details Get a Quote
CASP10 Knockout HeLa Cell Line EDJ-KQ21056 Human 843 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: